PYC 4.17% 12.5¢ pyc therapeutics limited

Ann: Change in substantial holding, page-35

  1. 5,874 Posts.
    lightbulb Created with Sketch. 17472
    And now Novartis has come back to Alnylam for a discovery-stage partnership, seeking an RNAi solution to end-stage liver failure.

    https://www.biopharmadive.com/news/novartis-alnylam-liver-failure-rna-research/616736/

    https://www.fiercebiotech.com/biotech/novartis-taps-alnylam-for-ambitious-push-to-fix-liver-function
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
12.5¢
Change
0.005(4.17%)
Mkt cap ! $571.5M
Open High Low Value Volume
12.5¢ 12.5¢ 12.0¢ $207.7K 1.671M

Buyers (Bids)

No. Vol. Price($)
30 2758503 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 442906 10
View Market Depth
Last trade - 13.01pm 17/07/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.